local coverage determination
National Government Services Expands Coverage for Bio-Techne's ExoDx Prostate Cancer Test
The assay will now be covered for patients with at least one prior negative biopsy who are considering a repeat biopsy and are thought to be at higher risk.
Local Coverage Determinations Roundup: Opko Health, Bio-Techne, LynxDx, MDxHealth
Medicare Administrative Contractor National Government Services released an LCD that would cover prostate cancer tests from multiple diagnostic companies.
Local Coverage Determinations Roundup: Castle Bio, SkylineDx
Palmetto GBA released a final local coverage determination that covers tests from Castle Biosciences and SkylineDx.
Four Years Into Foundational LCDs, Broader Reimbursement Coverage a Mixed Bag, Stakeholders Say
Premium
Palmetto GBA has expanded its decisions to cover classes of tests, rather than just one test, a move welcomed by most, but not all, of the industry.
Guardant Health Receives Medicare Coverage for Tissue-Based Cancer Test
The assay is covered under Medicare Administrative Contractor Palmetto GBA's local coverage determination for next-generation sequencing-based tests for solid tumors.